Literature DB >> 16623655

Aspirin in the treatment of acute migraine attacks.

Hans-Christoph Diener1, Christian Lampl, Peter Reimnitz, Michael Voelker.   

Abstract

Acetylsalicylic acid (aspirin or ASA) has been used for many years as an analgesic, antipyretic and anti-inflammatory drug. In recent years, evidence for its effectiveness in migraine headache has been demonstrated in several clinical trials. The effervescent highly buffered preparation of aspirin was shown to be effective, safe and well tolerated compared with placebo or other treatment options. The effervescent aspirin preparation is at least as effective as the combination of aspirin plus metoclopramide, but has fewer side effects. This review summarizes and analyzes clinical data of aspirin in the treatment of acute migraine attacks with respect to the different galenic formulations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16623655     DOI: 10.1586/14737175.6.4.563

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  16 in total

Review 1.  Calcitonin gene-related peptide (CGRP): a new target for migraine.

Authors:  Andrew F Russo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-08       Impact factor: 13.820

2.  Pharmacology.

Authors:  Hayrunnisa Bolay; Paul Durham
Journal:  Handb Clin Neurol       Date:  2010

Review 3.  Aspirin with or without an antiemetic for acute migraine headaches in adults.

Authors:  Varo Kirthi; Sheena Derry; R Andrew Moore; Henry J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

Review 4.  Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.

Authors:  Ann C Raddant; Andrew F Russo
Journal:  Expert Rev Mol Med       Date:  2011-11-29       Impact factor: 5.600

5.  Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.

Authors:  Christian Lampl; M Voelker; H C Diener
Journal:  J Neurol       Date:  2007-04-10       Impact factor: 4.849

Review 6.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

Review 7.  Over-the-counter triptans for migraine : what are the implications?

Authors:  Peer Tfelt-Hansen; Timothy J Steiner
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  The pharmacological management of migraine, part 1: overview and abortive therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-07

9.  Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia.

Authors:  Ann C Raddant; Andrew F Russo
Journal:  Headache       Date:  2014-02-11       Impact factor: 5.887

Review 10.  Aspirin with or without an antiemetic for acute migraine headaches in adults.

Authors:  Varo Kirthi; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.